Evidence map›Paper›PMID 34203201›Full record

ArticleCancers2021

Dissection of

Tony K H Chung, Graeme Doran, Tak-Hong Cheung, So-Fan Yim, Mei-Yung Yu, Michael J Worley, Kevin M Elias, Aaron R Thorner, Chandra Sekhar Pedamallu, Akinyemi I Ojesina and 21 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 7 institutions in 3 countries.

Tony K H ChungThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Graeme DoranFirefly Bioworks, Inc., Cambridge, MA 02139, USA.
Tak-Hong CheungThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
So-Fan YimThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Mei-Yung YuThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Michael J WorleyHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Kevin M EliasHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Aaron R ThornerHarvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.ORCID 0000-0002-9160-7881
Chandra Sekhar PedamalluHarvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Akinyemi I OjesinaDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Kei-Man LauThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Matthew D DucarHarvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.ORCID 0000-0003-4635-1300
Raymond R Y WongThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Vivian W WangMayo Clinic, Rochester, MN 55902, USA.
Anwesha NagHarvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Bruce M WollisonHarvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Audrey DalgarnoHarvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Jacqueline H S LeeThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.ORCID 0000-0002-3175-1144
Suet-Ying YeungThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Lo WongThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Neil S HorowitzHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Michelle R DavisHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Shuk-On A LeungHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Yi MuHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Samuel C MokMD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.ORCID 0000-0001-7013-1805
Paul K S ChanThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Michael S LawrenceBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Christopher P CrumHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Rossa W K ChiuThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Ross S BerkowitzHarvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
Yick-Fu WongThe Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Chinese University of Hong Kong · HKBrigham and Women's Hospital · USHarvard University · USBroad Institute · USMayo Clinic in Arizona · USThe University of Texas MD Anderson Cancer Center · USUniversity of Alabama at Birmingham · US

Funding

Hong Kong Research Grant Council 14101315
6 · The paper itself

Abstract

Personalized treatment of genetically stratified subgroups has the potential to improve outcomes in many malignant tumors. This study distills clinically meaningful prognostic/predictive genomic marker for cervical adenocarcinoma using signature genomic aberrations and single-point nonsynonymous mutation-specific droplet digital PCR (ddPCR). Mutations in

Indexed as

cervical adenocarcinomamutationPIK3CA

Identifiers

PMID34203201
PMCPMC8269188
OpenAlexW3177058874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.